Straumann Holding AG ROE 2012-2024 | SAUHY

Current and historical return on equity (ROE) values for Straumann Holding AG (SAUHY) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Straumann Holding AG ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $20.857B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $89.445B 21.60
Becton Dickinson (BDX) United States $52.031B 12.88
West Pharmaceutical Services (WST) United States $17.920B 35.81
Align Technology (ALGN) United States $14.756B 29.08
Cooper (COO) United States $14.455B 18.63
Henry Schein (HSIC) United States $8.469B 14.53
Merit Medical Systems (MMSI) United States $4.903B 23.70
DENTSPLY SIRONA (XRAY) United States $3.083B 9.21
CONMED (CNMD) United States $1.551B 11.17
STAAR Surgical (STAA) United States $0.896B 0.00
Pro-Dex (PDEX) United States $0.164B 17.96
Lifevantage (LFVN) United States $0.160B 16.52